Follow-up of Cochlear Implanted Children at 3 Years : Comparison of Electrophysiological and Speech-language Results
ImplantHear3
2 other identifiers
observational
50
1 country
1
Brief Summary
The objective of the study is to compare the responses recorded with automated cortical auditory evoked potentials, of children who had one or two cochlear implants for 3 years, and the results of the speech therapy assessment. 24 patients in the main ImplantHear3 study presented with disappointing language development or poor cortical responses. These patients will be followed up once a year, during a visit scheduled for the usual care, until 6 years post-implant, in order to make it possible to objectify the quality of the auditory rehabilitation received by the child.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 6, 2019
CompletedFirst Posted
Study publicly available on registry
December 10, 2019
CompletedStudy Start
First participant enrolled
January 13, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 13, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 13, 2024
CompletedSeptember 12, 2025
September 1, 2025
4.3 years
December 6, 2019
September 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Automated cortical auditory evoked potentials results
Latency and amplitude of the waves P1, N1, P2, N2.
Annual assessment performed during 3 years.
Speech therapy result
Percentage of recognition Open Set Words : * cochlear implant 1, * cochlear implant 2, * 2 cochlear implants together, * cochlear implant and hearing aid together.
Annual assessment performed during 3 years.
Secondary Outcomes (12)
Value of p (HearLab)
Annual assessment performed during 3 years.
Latencies P1, N1, P2, N2 (HearLab)
Annual assessment performed during 3 years.
Amplitudes P1, N1, P2, N2 (HearLab)
Annual assessment performed during 3 years.
Setting parameters
Annual assessment performed during 3 years.
Auditory rehabilitation
Annual assessment performed during 3 years.
- +7 more secondary outcomes
Study Arms (2)
Patients
Children implanted cochlear since 3 years in uni or bilateral and followed in the pediatric otolaryngology department of Necker-Enfants Malades Hospital.
Patients with disappointing language development or poor cortical responses
Children having participated in the main ImplantHear3 study and who present with disappointing language development or poor cortical responses.
Interventions
Recording of automated cortical auditory evoked potentials in response to a vocal stimulus.
* Cortical auditory evoked potentials Recording of automated cortical auditory evoked potentials in response to a vocal stimulus. * Recording of cortical auditory evoked potentials in response to a click * Realization of electrical potentials via the implant Followed up once a year during a visit scheduled for usual care, for 3 years, that to say up to 6 years post-implant.
Eligibility Criteria
Children implanted for 3 years, in unilateral or bilateral and followed in the pediatric otolaryngology department of the Necker-Enfants Malades Hospital in Paris.
You may qualify if:
- Patient who has received one or two cochlear implants between August 1, 2016 and November 1, 2017 and after 3 years of follow-up for the first implant.
- Non-opposition of the holders of the parental authority and the patient.
You may not qualify if:
- Patients over 15 years of age at implantation.
- Patient relocated between August 1, 2016 and November 1, 2017.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpital Necker-Enfants Malades
Paris, 75015, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Natalie Loundon, MD, PhD
Assistance Publique - Hôpitaux de Paris
- STUDY DIRECTOR
Isabelle Rouillon, MD
Assistance Publique - Hôpitaux de Paris
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 6, 2019
First Posted
December 10, 2019
Study Start
January 13, 2020
Primary Completion
April 13, 2024
Study Completion
April 13, 2024
Last Updated
September 12, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share